These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

170 related items for PubMed ID: 4668562

  • 1. Anaesthesia and serum creatine phosphokinase levels in patients with Duchenne's pseudohypertrophic muscular dystrophy.
    Richards WC.
    Anaesth Intensive Care; 1972 Nov; 1(2):150-3. PubMed ID: 4668562
    [No Abstract] [Full Text] [Related]

  • 2. Serum creatine phosphokinase in the detection of carriers of Duchenne's muscular dystrophy in Northern Ireland.
    McCormick D, Allen IV.
    Ulster Med J; 1976 Nov; 45(1):79-83. PubMed ID: 936362
    [No Abstract] [Full Text] [Related]

  • 3. Fetal-blood creatine phosphokinase in the diagnosis of Duchenne's muscular dystrophy.
    N Engl J Med; 1978 Jun 29; 298(26):1479-80. PubMed ID: 652021
    [No Abstract] [Full Text] [Related]

  • 4. [Modifications of serum creatine phosphokinase activity under the influence of lithium gluconate in Duchenne's myopathy].
    Chazot G, Fournis Y, Robert JM, Aimard G, Devic M.
    Lyon Med; 1972 Nov 29; 228(17):421-5. PubMed ID: 4658522
    [No Abstract] [Full Text] [Related]

  • 5. Duchenne's muscular dystrophy in six siblings. The case for early diagnosis and neonatal screening.
    Moosa A.
    S Afr Med J; 1982 Nov 13; 62(21):765-7. PubMed ID: 7135141
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Fortuitous detection of a sporadic carrier of Duchenne's muscular dystrophy.
    Hanson JW, Zellweger H, Afifi AK, McCormick WF.
    Humangenetik; 1968 Nov 13; 6(1):34-9. PubMed ID: 5699892
    [No Abstract] [Full Text] [Related]

  • 9. Serum enzyme lowering and other effects of diethylstilbestrol (DIES) in Duchenne's muscular dystrophy (DMD).
    Cohen L, Morgan J, Schulman S, Lawrence A.
    J Lab Clin Med; 1971 Nov 13; 78(5):797-8. PubMed ID: 5128833
    [No Abstract] [Full Text] [Related]

  • 10. Variable effects of corticosteroid treatment of serum enzyme activities in Duchenne's muscular dystrophy.
    Cohen L, Morgan J, Bozyk ME.
    Res Commun Chem Pathol Pharmacol; 1977 Jul 13; 17(3):529-38. PubMed ID: 70832
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Change of serum creatine phosphokinase activity after exercise in Duchenne type of progressive muscular dystrophy.
    Nakane K.
    Nagoya Med J; 1972 Feb 13; 17(3):203-16. PubMed ID: 5050757
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Serum creatine kinase and sulphydryl concentration after ischemic forearm work in patients and carriers of Duchenne's progressive muscular dystrophy].
    Moser H, Wiesmann U.
    Klin Wochenschr; 1971 Apr 15; 49(8):488-94. PubMed ID: 5574169
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.